Related by context. All words. (Click for frequent words.) 62 Richard Pazdur 60 Richard Pazdur MD 56 Steven Galson MD MPH 55 Mace Rothenberg 55 Steven Galson acting 54 Dr. Debra Birnkrant 53 Kirk Garratt 53 Pedro Lichtinger 53 Dr. Mace Rothenberg 53 Len Lichtenfeld MD 53 Steven Galson MD 53 Nicole Onetto MD 52 Orville G. Kolterman 52 Barry Straube 52 Roger Perlmutter Amgen 52 Kemal Malik 51 Jeffrey Shuren 51 Steven Galson 51 Sandra Kweder 51 Alessandro Riva 51 Dr. Joyce Korvick 51 Randall Lutter 50 Eric Winer 50 spokeswoman Lenore Gelb 50 Jean Pierre Lehner 50 oncologic 50 Marc Cluzel 50 Rachel Behrman 50 Patricia Hartge 50 hoFH patients 50 Dr. Karen Midthun 50 Geno Germano 50 Elmar Schnee 50 Dr. Steven Galson 50 Jorge Cortes MD 50 Donna Ambrosino 50 Richard Schilsky 49 Vojo Vukovic MD Ph.D. 49 Kidney transplantation 49 William Shrank 49 Oncology Drug 49 Daniel Junius 49 Bruce Kuhlik 49 Vincent Cogliano 49 Dr. Gail Cawkwell 49 Paolo Pucci chief 49 Breast Oncology 49 Dr. Badrul Chowdhury 49 Rachel Ballard Barbash 49 Vitro Diagnostic Device 49 Dr. Stephen Sundloff 49 Elliott Sigal 49 NK Ganguly 49 Camillo Ricordi MD 49 TroVax ® 49 refractory colorectal cancer 49 Surgical resection 48 Paolo Paoletti MD 48 curative therapy 48 Louise Van Diepen 48 Vicki Pontius 48 Lisa N. Drakeman 48 June Almenoff MD 48 Roxana Mehran MD 48 Yvonne Greenstreet 48 Jason Gorevic 48 Lorianne Masuoka MD 48 Rosen ViroPharma 48 Alfred I. Neugut 48 sorafenib Nexavar 48 Dr. Jeffrey Shuren 48 Dr. Joseph Kvedar 48 Iris Loew Friedrich 48 Paolo Paoletti 48 Belldegrun 47 Dr. Debbie Saslow 47 Dr. Feczko 47 Ahmanson UCLA Cardiomyopathy 47 Janet Woodcock MD 47 Avastin Tarceva 47 leukemia multiple myeloma 47 surgically resectable 47 Di Bisceglie 47 Cancer Immunobiology Center 47 oral clodronate 47 W. Craig Vanderwagen 47 Roche Herceptin 47 relapsed SCLC 47 Cristofanilli 47 Janet Woodcock 47 Dr. Raynard Kington 47 Kevin De Cock 47 Eric K. Rowinsky 47 HER2 positive cancers 47 OSUCCC James 47 samalizumab 47 Hal Barron 47 authority Gurian Sherman 47 Ph.D MPH 47 Raynard Kington 47 squamous non 47 allogenic stem cell 47 Neuro Oncology Program 47 Bram Zuckerman 47 Ronald O. Valdiserri 47 Keiji Fukuda WHO 46 Dr. Barbara Alving 46 Dino Dina 46 ICD therapy 46 Glenn Hackbarth 46 Foodborne Bacterial 46 Bruce Gellin 46 Pulmonary Allergy 46 Dr. Rafel Rieves 46 postoperative pulmonary 46 Dr Rasiah 46 Jeff Shuren 46 axitinib 46 Herb Kuhn 46 Troyen Brennan MD 46 Acute myelogenous leukemia 46 Dr. Janet Woodcock 46 cyclophosphamide chemotherapy 46 TTF Therapy 46 cabazitaxel 46 indolent NHL 46 prolongs survival 46 Peter Ashkenaz 46 Anne Schuchat MD 46 Jesse Blout San Francisco 46 Jean Jacques Bienaime 46 antithrombotic therapy 46 Lonny Reisman MD 46 Christie Ballantyne 46 Jason Gurda 45 Dr. Rhonda Medows 45 Vivianne Chaumont 45 haematologic malignancies 45 metastatic gastric 45 endocrine therapies 45 Elizabeth Nabel 45 Liver transplantation 45 Amgen Vectibix 45 Edwin Hemwall 45 FDA Deborah Autor 45 Dr. Sandra Kweder 45 Marie Paule Kieny WHO 45 postoperative chemotherapy 45 intra arterial chemotherapy 45 thetreatment 45 neoadjuvant therapy 45 Brian JG Pereira 45 squamous cell lung cancer 45 Oliver Sartor 45 standard chemotherapy regimen 45 castration resistant hormone refractory 45 thromboembolic disease 45 Temodar ® 45 Evoltra ® 45 smoldering multiple myeloma 45 Karel Reisz suffered 45 Sudhir Agrawal D.Phil 45 Dr. Herman Kattlove 45 Anesthesia Analgesia 45 Dr. Deepak Bhatt 45 Dr. Deepa Subramaniam 45 Gail Boudreaux 45 postoperative radiotherapy 45 Diabetes Endocrinology 45 Michael H. Tardugno 45 figitumumab 45 ADVEXIN therapy 45 preoperative chemotherapy 45 Deborah Bachrach 45 gadobutrol 45 allogeneic HSCT 44 Mofenson 44 Campos Outcalt 44 metastatic dermatofibrosarcoma protuberans DFSP 44 CMV disease 44 Barbara Alving 44 Dr. Wolfgang Wein 44 relapsed refractory aggressive 44 ZOLINZA 44 Eliezer Zomer Ph.D. 44 Daud bodyguards 44 taxane refractory 44 anidulafungin 44 Sandra Kweder MD 44 Shigeru Omi 44 stage IIIB IV 44 advanced hepatocellular carcinoma 44 Matthew Emmens 44 heavily pretreated 44 drug Treanda 44 Cheson 44 metastatic renal cell 44 cardiac revascularization 44 Squamous cell 44 Stan Rosenstein 44 John E. Niederhuber 44 Trevor Mundel 44 Adjuvant chemotherapy 44 Dr. Joan Duwve 44 Joseph Zubretsky 44 immune suppressing medication 44 Elizabeth Battaglino Cahill 44 Dr. Aman Buzdar 44 minimally symptomatic 44 Richard Pazdur director 44 Hervé Hoppenot President 44 Nothing Wadden 44 Hematologic Neoplasia 44 Jevtana 44 H. Kirn 44 Rituxan rituximab 44 R0 resection 44 pancreatic islet cell 44 relapsed ovarian cancer 44 ZACTIMA TM ZD# 44 Norbert Bischofberger PhD 44 colorectal ovarian 44 Troxatyl 44 CDER FDA 44 cytoreduction 44 Kattlove 44 Fibrillex 44 immune modulating 44 Jeanne Lambrew 44 temsirolimus 44 AstraZeneca Iressa 44 HER2 positive breast cancer 44 advanced HER2 positive 44 JoAnn Manson chief 44 oxaliplatin Eloxatin 44 BEXXAR Therapeutic Regimen 44 resistant hormone refractory 44 dasatinib Sprycel 44 SUTENT ® 44 TNF blocker therapy 44 Pegloticase 44 hematological malignancy 44 CDER 44 Steven Nissen 44 hematological diseases 44 Dr. Lawrence Deyton 44 Scott Serota 44 Gimeno Guerrero 44 Bevacizumab Avastin 43 pulls Darvon painkiller 43 Critical Path Programs 43 curability 43 Pneumonia vaccine 43 McClellan MD PhD 43 refractory Hodgkin 43 anti angiogenic agents 43 Gary Ghiselli 43 Vidaza azacitidine 43 overlapping toxicities 43 Charlie Gilks 43 Dr. Bram Zuckerman 43 BLA filing 43 chairman Glenn Hackbarth 43 Thomas Laughren 43 BUDGET DIRECTOR Peter Orszag 43 chemotherapy hormonal therapy 43 lymphomas leukemias 43 macrovascular events 43 medically inoperable 43 FDA Oncologic Drugs 43 vaccine Fauci 43 ADVERSE EVENTS 43 liver metastasis 43 XL# SAR# 43 metastatic kidney 43 FOLFOX chemotherapy 43 pharmacologic therapies 43 adverse cytogenetics 43 David Wajsgras Raytheon 43 recurrent metastatic 43 Related Anemia 43 steroid refractory 43 Randall Lutter Ph.D. 43 Liprotamase 43 Spokeswoman Debbie Tanna 43 containing abacavir 43 pulmonary exacerbations 43 Warfarin Coumadin 43 Her2 positive 43 Dr. Gideon Koren 43 Mark Willenbring 43 erlotinib Tarceva 43 Trevor Mundel MD 43 Scott P. Serota 43 kidney urologic 43 cisplatin chemotherapy 43 tyrosine kinase inhibitors TKIs 43 Pediatric Neurological Surgery 43 Jay Angoff 43 Dr. Kate Gelperin 43 Teverelix 43 medullary thyroid cancer 43 Noxafil 43 Urologic Oncology 43 Simulect 43 hormone refractory 43 Aggrastat ® tirofiban hydrochloride 43 Camptosar ® 43 Genetic Therapies Directorate 43 Mark HN Corrigan 43 malignant pleural mesothelioma 43 recurrent glioblastoma multiforme 43 Gastroenterology Hepatology 43 Dr. Maria Neira 43 agency carcinogen classifications 43 antiplatelet therapies 43 VIDAZA ® 43 Precious Matsoso 43 colorectal cancer liver metastases 43 differentiated thyroid 43 Trevor Fetter 43 Acute myeloid leukemia 43 Dr. Gulfo 43 Jonathan Scharfen 43 vandetanib 43 Inhaled nitric oxide 43 Dara Corrigan 43 metastatic GIST 43 Bruce Roberts RPh 43 Jonathan Perlin 43 Tomi Galin 43 aromatase inhibitor therapy 42 therapeutic regimens 42 anthracyclines taxanes 42 Vitrasert R 42 FUSILEV enhances 42 Dr. Karl Mettinger 42 Patricia O'Looney 42 Joel Owerbach 42 commercializes oncology 42 Bruce Yarwood 42 Advanced Melanoma 42 forodesine 42 Panzem 42 pazopanib 42 angiogenesis inhibition 42 Bergenstal 42 P. aeruginosa infections 42 mismatched bone marrow 42 malignant growths 42 Myelofibrosis 42 granted Ortec 42 Dr. Andreas Barner 42 adjuvant therapies 42 paclitaxel Taxol ® 42 Samuel Z. Goldhaber 42 Chemophase 42 Gerald Dal 42 Rajesh C. Shrotriya 42 Biochemical Genetics 42 Atul Pande MD 42 refractory metastatic 42 Dr. Barry Straube 42 Immunotherapeutic 42 Not Approvable 42 candidemia 42 metastatic colorectal 42 Cytoxan 42 hormonally responsive 42 Kenneth Olden 42 Cethromycin 42 cranial irradiation 42 Moncef Slaoui 42 Howard Fillit MD 42 nonsmall cell lung cancer 42 Bioaccelerate compounds under 42 Riluzole 42 Joseph M. Zubretsky 42 Bezielle 42 skeletal metastases 42 nonhormonal 42 Pixuvri 42 Marcia Crosse 42 Anthracycline 42 Susan B. Shurin 42 Michael McRaith 42 treating neuropathic pain 42 antitumor effect 42 Radical prostatectomy 42 UCSF Comprehensive Cancer 42 Guerma 42 Eric Kossoff 42 Gene Saragnese 42 gastrointestinal mucositis 42 refractory angina 42 gastrointestinal stromal tumors 42 antibiotic prophylaxis 42 BRAF inhibitors 42 torsemide ER 42 foodborne bacterial 42 aromatase inhibitors AIs 42 SIADH 42 Anti infective 42 Kauffman MD Ph.D. 42 Allovectin 7 ® 42 prognostically 42 Heath Schiesser 42 Novartis AG Gleevec 42 Romiplostim 42 mTOR kinase 42 Antidepressant medications benefit 42 prescriber surveys 42 postoperative morbidity 42 thoracoscopic lobectomy 42 hormone deprivation 42 Debby Herbenick associate 42 Charlene Frizzera 42 Melville Engle 42 CMV infections 42 Senak 42 IRX 2 42 novel immunotherapies 42 Susan Besio 42 ARCOXIA 42 ganetespib 42 Interventional Vascular Therapy 42 Torisel 42 androgen ablation therapy 42 tanespimycin 42 Cytarabine 42 obatoclax 42 intracerebral hemorrhage 42 Lilly Alimta 42 Ira Loss 42 thrombotic complications 42 cardiotoxicity 42 GnRH agonists 42 MGN# 42 anthracycline containing 42 Anthony Fauci 42 Oral Cavity Soft Palate 42 Seewaldt 42 Talabostat 42 Pulmonary arterial hypertension 42 transplantation HCT 42 microsphere therapy 42 Gleevec Glivec 42 Dr. Ronald Valdiserri 42 MYLOTARG 42 chemoradiation therapy 42 Soiffer 42 anthracycline taxane 42 dalbavancin 42 pegfilgrastim 42 pain palliation 41 Graft Versus Host 41 metastatic uveal melanoma 41 Dr. Bernhard Kirschbaum 41 Pharmacoeconomics 41 Shelton Earp 41 Myelodysplastic syndromes MDS 41 Drug Evaluation 41 pancreatic lung 41 influenza antiviral medications 41 chronic HBV 41 Candace Kendle PharmD 41 refractory ovarian cancer 41 supplemental Biologics License Application 41 anticancer treatments 41 Barrett Toan 41 multivessel coronary artery 41 Mateczun 41 precancerous condition 41 Carolyn Clancy 41 Douglas Throckmorton 41 Stephen Huhn 41 MAXY G# 41 BRAF V# mutation 41 myelofibrosis 41 skin sparing mastectomy 41 paclitaxel poliglumex 41 Dr. Vitetta 41 Abiraterone acetate 41 investigational therapies 41 Oncologic Drugs Advisory 41 androgen ablation 41 treating sarcoma testicular 41 CYP#A# substrate 41 Trevor Fetter Tenet 41 NOXAFIL 41 adalimumab Humira 41 PROCRIT 41 FROVA 41 M.D. Ph.D. 41 signal transduction inhibitors 41 recurrent Hodgkin 41 Lung transplantation 41 colorectal liver metastases 41 antiinfective products 41 spinal metastases 41 TEMODAL 41 Hematologic 41 Merck boceprevir 41 allogeneic stem cell 41 Immunosuppressive 41 antiplatelet drugs 41 Gastrointestinal Oncology 41 Roy Jeffus 41 immuno suppressive 41 anticholinergic agents 41 thalidomide Thalomid 41 P. Koestler Ph.D. 41 glucocorticoid induced osteoporosis 41 temozolomide Temodar 41 Pediatric Allergy 41 Akshay Vaishnaw MD Ph.D. 41 stent thrombosis blood clots 41 myelogenous leukemia 41 spokeswoman Trish Nicasio 41 malabsorptive 41 Kate Gelperin 41 CorVue 41 heterozygous FH 41 Advaxis Phase 41 monoclonal antibody therapies 41 abiraterone 41 Kathy Giusti Founder 41 Deborah Autor director 41 leukemia lymphoma multiple myeloma 41 antiestrogen 41 venous thromboembolic disease 41 motesanib 41 gastrointestinal stromal tumor GIST 41 Beth Abramson 41 metastatic sarcomas 41 Dr. Edward Scolnick 41 AdweekMedia contributing editor 41 Duane Goossen 41 locoregional 41 chemotherapeutic regimens 41 Inhaled insulin 41 colorectal lung 41 moderate renal impairment 41 Spokeswoman Amy Cianciaruso 41 TNFerade TM 41 Telavancin 41 Chronic lymphocytic leukemia 41 Andrew Agwunobi 41 Jay Deady Eclipsys 41 Joel Ario 41 Pulmonary Diseases 41 Merck Isentress 41 severe hepatic dysfunction 41 mTOR inhibitors 40 invasive fungal 40 Arden Bement 40 Lori Parham 40 Dal Pan 40 Accelerated Partial Breast Irradiation 40 Cellular Tissue 40 Mycotic Diseases 40 cirrhosis liver failure 40 KRAS mutant tumors 40 Potiga 40 Evoltra TM 40 Hematologic Malignancies 40 Submits Response 40 GPhA 40 non squamous 40 Altshuler MD Ph.D. 40 endometrial hyperplasia 40 ablative therapy 40 Eric Hammelman senior 40 Dr. Arnon Afek 40 IL# PE#QQR 40 Venous thromboembolism 40 TransVax 40 alkylating agent 40 Elizabeth G. Nabel 40 Activa Therapy 40 Michael Dansinger 40 HER2 positive breast 40 Kenneth Moritsugu 40 PCNSL 40 Cancer Survivorship 40 diagnose coronary artery 40 oxymorphone ER 40 Androxal ® 40 Everolimus 40 pertuzumab 40 receiving chemoradiation therapy 40 Acting Surgeon General 40 standard chemotherapy regimens 40 Pleural mesothelioma 40 treat enlarged prostate 40 Debasish Roychowdhury MD 40 invasive candidiasis 40 Hematologic Oncology 40 OnDose TM 40 Pazdur 40 evaluating picoplatin 40 GvHD 40 BZL# 40 psoriatic arthritis PsA 40 Loretta Tuell staff 40 ovarian suppression 40 Bone marrow transplant 40 Leonard Saltz 40 imatinib Gleevec ® 40 Surgical excision 40 invasive aspergillosis 40 AVASTIN 40 Glaxo Serevent 40 Pulmonary Vascular Disease 40 Charles Ganley 40 congenital fibrinogen deficiency 40 intravascular hemolysis 40 Amylin Byetta 40 Gamelli 40 Relapsing remitting MS 40 Alimta pemetrexed 40 Bioenvision compounds under 40 bone metastases 40 Beall Ph.D. 40 Farzad Mostashari 40 Outcomes Research 40 refractory acute myeloid 40 Fergus Macbeth 40 Dementia Related Psychosis 40 pancreatic NET 40 Outcomes Research ISPOR 40 relapsed leukemia 40 therapeutic armamentarium 40 hereditary antithrombin deficient 40 receiving XGEVA 40 ELACYT 40 HER2 positive metastatic breast 40 infections bloodstream infections 40 Pulmonary Allergy Drugs 40 Howard Frumkin 40 lipid lowering therapies 40 Wysenski 40 pancreatic ductal 40 imatinib Gleevec 40 Pelvic inflammatory 40 demonstrated antitumor activity 40 Glioblastoma multiforme GBM 40 Lisette Mondello 40 psoriasis inflammatory bowel 40 IMC #B 40 Robert Ursano 40 Panzem R 40 myelodysplastic syndromes 40 Octreotide 40 Dr Peter Piot 40 gangrene amputation 40 LibiGel ® 40 vascular anatomy 40 Plavix cautioning 40 doublet chemotherapy 40 Robert Kolodner 40 fibrate drugs 40 Tasigna prolongs 40 antimicrobial prophylaxis 40 Neuro Oncology 40 Infections Diseases 40 SERCA2a 40 pancreatic colon 40 Avastin Erbitux 40 dual endothelin receptor antagonist 40 Joseph Rannazzisi deputy 40 metastatic malignant 40 GVAX Pancreas Vaccine 40 cardiac allograft vasculopathy 40 Robert Motzer MD 40 osteoporotic compression fractures 40 Neck Cancers 40 Acute Radiation Syndrome 39 opioid tolerant adult 39 Copays 39 Archexin 39 Amy Allina 39 steroid refractory GvHD 39 lenalidomide dexamethasone 39 FluCide 39 bioidentical estrogen 39 abdominal abscesses 39 Bar Chama 39 membranous nephritis 39 reversing heparin 39 Nutrition Metabolism 39 SPARLON 39 Watchful waiting 39 Cancer Immunotherapy 39 nephropathic cystinosis cystinosis 39 Dr. Adrienne LeBailly 39 chronic hemodialysis 39 chronic leukemias 39 Rasilez HCT 39 Biologics Evaluation 39 SILENOR 39 hypereosinophilic syndrome 39 sitagliptin Januvia 39 spokesman Fernando Senra 39 STELARA ® 39 docetaxel Taxotere ® 39 immunosuppressive therapies 39 Ophthalmic Drugs Advisory 39 antiangiogenic agents 39 cangrelor 39 triphendiol 39 Alan Mittermaier 39 UAB Comprehensive Cancer 39 Dr. Len Horovitz 39 Takashi Yokota 39 Thoracic Oncology 39 Biologic License Application BLA 39 Metastatic 39 chronic angina 39 hematological disorders 39 gemcitabine chemotherapy 39 FX McCahill 39 Sarita Nagpal 39 nonsquamous 39 CINTREDEKIN BESUDOTOX 39 recurrent glioma 39 Oral mucositis 39 Minimally invasive surgery 39 INSPIRE Trial Phase III 39 immunological reaction 39 chemopreventive agents 39 diabetic kidney 39 Eric Goosby 39 called salmonella saintpaul 39 endothelin receptor antagonists 39 fulvestrant 39 Gefitinib 39 Loretta Fuddy Hawaii 39 renal toxicity 39 talactoferrin 39 systemic invasive fungal 39 Biostatistical 39 FDA Antiviral Drugs 39 Dr. Frank Vocci 39 Troyen A. Brennan 39 Walt Rosebrough 39 Clinical Effectiveness 39 Drug Administration Oncologic Drugs 39 antiinflammatory drugs 39 UNMC Eppley Cancer 39 Digestive Diseases 39 Glivec imatinib 39 cystic fibrosis chronic pancreatitis 39 CHOP chemotherapy 39 Genitourinary Oncology 39 Xie Fuzhan 39 treating cancerous tumors 39 Molecular Pathogenesis 39 induce remission 39 FDA Endocrinologic 39 pharmacologic intervention 39 Elias Zerhouni 39 Dr Anders Nordström 39 liprotamase 39 neoadjuvant setting 39 Alan Silman 39 Inflammatory diseases 39 Nora D. Volkow 39 severe hypersensitivity reactions 39 asymptomatic hyperuricemia 39 Sandra Kweder deputy 39 Jessica Santillo spokeswoman 39 M. Perlmutter 39 chemoprevention 39 metastatic bladder 39 Dr. Bruce Gellin 39 immune suppressing 39 patients undergoing chemotherapy 39 Director Raynard Kington 39 maximally tolerated lipid lowering 39 Cao Minh Quang 39 Research CDER 39 venous thromboembolic events 39 Pat El Hinnawy 39 Clot busting 39 Vectical TM Ointment 39 MRMIB 39 genital warts sexually transmitted 39 CCR9 antagonist 39 infliximab Remicade 39 Zenpep 39 NEUMUNE 39 Maureen LaCroix 39 chronic noncancer pain 39 DCVax R 39 GPIIb IIIa 39 TAXOTERE ® 39 Novartis AG Galvus 39 commercialize deforolimus 39 HQK 39 Hydroxyurea 39 aldosterone antagonists 39 neovascular diseases 39 Anne Dunkelberg 39 Metabolic Drugs Advisory 39 Abdul Rahim Deciwal 39 radiation therapy SBRT 39 Rocky Mountain Poison 39 Bruce Weitzberg CEO 39 OsmoPrep 39 Bernadette Dunham 39 Zemiva TM 39 anti angiogenic therapy 39 hematopoietic cell 39 Linjeta TM 39 mutant KRAS 39 Ciccarone Preventive Cardiology 39 Arixtra ® 39 Sherri McGarry 39 Foodborne Waterborne 39 mycotic diseases 39 FDA Advisory Panel 39 pulmonary fungal infections 39 alogliptin 39 pancreatic neuroendocrine tumors 39 Galson 39 Helena Foulkes 39 OHRP 39 de novo kidney transplant 39 Novartis AG Foradil 39 lucinactant 39 surgical debulking 39 leukemia myeloma 39 bone metastasis 39 Zavesca 39 Nebido 38 clinically heterogeneous 38 Pulmonary hypertension 38 postsurgical 38 Platinol ® 38 recurrent glioblastoma multiforme GBM 38 lymph node removal 38 Luis Rosero 38 YONDELIS 38 ALGRX 38 Effexor venlafaxine 38 Timothy Ulatowski 38 Marilyn Tavenner 38 Arthur S. Przybyl 38 Tel Aviv Sourasky Medical 38 immunosuppression therapy 38 Gleevec resistant 38 Liver toxicity 38 gastrointestinal stromal tumors GIST 38 antiangiogenic drugs 38 recurrent NSCLC 38 chronic periodontitis 38 Emory Transplant 38 Dan Fogleman 38 Anti Infective 38 Erythropoietic therapies may 38 Dr. Jihad Kaouk 38 QNEXA 38 ROVNER Well 38 cytotoxic therapy 38 Doribax 38 stated Bruce Yarwood 38 Combunox 38 sitaxsentan 38 MabThera Rituxan 38 Liver Disease 38 esophageal candidiasis 38 gastroenterology neurology 38 curative treatments 38 BEACOPP 38 Dr. Rohack 38 MK #B 38 perioperative morbidity 38 preventing recurrences 38 conventional chemotherapies 38 Michael Walcoff 38 HIV AIDS Viral Hepatitis 38 impair fertility 38 Device Evaluation 38 Wendy Zenker 38 ICON Clinical 38 John O. Agwunobi 38 Ellen Terpstra 38 guanfacine extended release 38 bony metastases 38 Barbara Alving MD 38 Metabolic Diseases 38 Fibrillex TM 38 Acute Radiation Syndrome ARS 38 NIAMS 38 uric acid lowering 38 Daniel Rotrosen MD 38 Kurt J. Hilzinger 38 Cheap generic levitra 38 haematological malignancies 38 CYT# potent vascular disrupting 38 Daschle withdraws 38 Hepatocellular Carcinoma HCC 38 combinability 38 Li Fraumeni Syndrome 38 banned Darvon Darvocet 38 severe Primary IGFD 38 Vandetanib 38 ovarian hyperstimulation syndrome OHSS 38 Metabolic Disorders 38 Nutrition Physical Activity 38 neuroendocrine cancers 38 advanced epithelial ovarian 38 Kathleen Stoll 38 Perforomist ™ Inhalation Solution 38 localized prostate 38 economist Andrea Sisko 38 palliative radiotherapy 38 Afresa 38 rivaroxaban Xarelto 38 immuno suppression 38 FDA Accepts 38 LHRH antagonists 38 Exploratory IND 38 postexposure 38 anticancer therapy 38 GnRH agonist 38 SIMPONI ® 38 diseases fat malabsorption 38 anthracyclines 38 Mitomycin C 38 Pirfenidone 38 Clinical Practice Guidelines 38 Receives Approvable Letter 38 Aciphex R 38 Anti virals 38 TNF alpha antagonist 38 Cutaneous Oncology 38 IV antihypertensive 38 See CLINICAL PHARMACOLOGY 38 dopaminergic therapy 38 malignant pheochromocytoma 38 concurrent chemoradiation 38 Chronic pancreatitis 38 Minister Eka Sguladze 38 approvability 38 Relapsed Refractory Multiple Myeloma 38 multiple sclerosis psoriasis 38 John Rother AARP 38 Nancy Kichak 38 nonsteroidal antiinflammatory drugs 38 tolerability profiles 38 EGFR tyrosine kinase inhibitors 38 Gene Therapies 38 urothelial cancer 38 Joel Gurin 38 myeloablative 38 Combivir Kivexa 38 Arthritis Advisory 38 anticlotting 38 patriotism Gration 38 Carl Casale 38 curable cancers 38 homozygous familial hypercholesterolemia 38 skin sparing mastectomies 38 severe oral mucositis 38 potentially hepatotoxic 38 P. Byrnes Lincare 38 idiopathic pulmonary fibrosis IPF 38 immunotherapeutic approaches 38 esophageal gastric 38 thrombin inhibitor 38 Nils Hagen Frederiksen 38 erlotinib Tarceva ® 38 Severe hypersensitivity reactions 38 SNT MC# 38 chemotherapies 38 Paraplatin ® carboplatin 38 fibrocystic disease 38 Fondaparinux 38 diabetic gastroparesis 38 postoperative AF 38 angiogenic therapy 38 Jason Helgerson 38 carcinoid 38 immunosuppressant drug 38 antiviral therapy 38 Scheineson 38 blood clot dissolving 38 pharmacological therapy 38 CBER 38 Jim Gulliford 38 Julie Dekom Membership 38 Tyrima 38 Jonsson Comprehensive Cancer 37 Pulmonary fibrosis 37 Eric Laroche 37 Pharmacoepidemiology 37 Tectin TM